Mark J Sculpher
Overview
Explore the profile of Mark J Sculpher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
3924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chivardi C, Morgan H, Sculpher M, Clayton T, Evans R, Dodd M, et al.
Circ Cardiovasc Qual Outcomes
. 2023 Nov;
17(1):e010533.
PMID: 37929587
Background: Percutaneous coronary intervention (PCI) is frequently undertaken in patients with ischemic left ventricular systolic dysfunction. The REVIVED (Revascularization for Ischemic Ventricular Dysfunction)-BCIS2 (British Cardiovascular Society-2) trial concluded that PCI...
2.
Soares M, Sculpher M, Claxton K
Med Decis Making
. 2021 Feb;
41(3):258-260.
PMID: 33629616
No abstract available.
3.
Padula W, Sculpher M
Ann Intern Med
. 2020 Sep;
174(1):80-85.
PMID: 32986487
The United States is one of the few high-income countries not to apply economic evaluation routinely to health care decision making on a national level, yet it excels at spending...
4.
Elliott R, Camacho E, Jankovic D, Sculpher M, Faria R
BMJ Qual Saf
. 2020 Jun;
30(2):96-105.
PMID: 32527980
Objectives: To provide national estimates of the number and clinical and economic burden of medication errors in the National Health Service (NHS) in England. Methods: We used UK-based prevalence of...
5.
Soares M, Sculpher M, Claxton K
Med Decis Making
. 2020 May;
40(4):448-459.
PMID: 32441558
Well-established methods of economic evaluation are used in many countries to inform decisions about the funding of new medical interventions. To guide such decisions, it is important to consider what...
6.
Woods B, Sideris E, Sydes M, Gannon M, Parmar M, Alzouebi M, et al.
Eur Urol Oncol
. 2019 Jun;
1(6):449-458.
PMID: 31158087
Background: Results from large randomised controlled trials have shown that adding docetaxel to the standard of care (SOC) for men initiating hormone therapy for prostate cancer (PC) prolongs survival for...
7.
Neumann P, Kim D, Trikalinos T, Sculpher M, Salomon J, Prosser L, et al.
Med Decis Making
. 2018 Sep;
38(7):767-777.
PMID: 30248277
Objectives: In 2016, the Second Panel on Cost-effectiveness in Health and Medicine updated the seminal work of the original panel from 2 decades earlier. The Second Panel had an opportunity...
8.
Soares M, Walker S, Palmer S, Sculpher M
Med Decis Making
. 2018 Mar;
38(4):495-508.
PMID: 29529918
In recent years, Health Technology Assessment (HTA) processes specific to diagnostics and prognostic tests have been created in response to the increased pressure on health systems to decide not only...
9.
Faria R, Soares M, Spackman E, Ahmed H, Brown L, Kaplan R, et al.
Eur Urol
. 2018 Feb;
73(6):e151-e152.
PMID: 29463435
No abstract available.
10.
Revill P, Walker S, Cambiano V, Phillips A, Sculpher M
PLoS One
. 2018 Jan;
13(1):e0190283.
PMID: 29293611
Background: The WHO HIV Treatment Guidelines suggest routine viral-load monitoring can be used to differentiate antiretroviral therapy (ART) delivery and reduce the frequency of clinic visits for patients stable on...